Evaluating the Prevalence of Optimal Neurodevelopmental Outcome at 4.5‐Years in Children Previously on Ventricular Assist Device Support
Pediatric Transplantation · 2026
DOI: 10.1111/petr.70276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Shannon Oliver und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Heart-Assist Devices, Neurodevelopmental Disorders, Heart Failure. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The majority of patients who undergo ventricular assist device (VAD) implant in childhood survive to adulthood. This study examined the neurodevelopmental trajectory post VAD and determined factors associated with non‐optimal outcome.
Methods
Patients implanted with a VAD aged < 6 years between 01/2006 and 12/2020, who underwent assessment at 4.5–7‐years of age (and > 6 months post decannulation) with the Complex Pediatric Therapies Follow‐up Program were included in a prospective‐inception‐cohort study. Optimal neurodevelopmental outcome was defined as scores of ≥ 80 on the Wechsler Preschool and Primary Scales of Intelligence, the Beery‐Buktenica Developmental Test of Visual‐Motor Integration and on the Adaptive Behavior Assessment System, in the absence of cerebral palsy, permanent hearing loss, visual impairment, or seizure disorder. Firth multiple regression analysis was used to determine independent factors associated with non‐optimal outcome.
Results
A total of 74 patients underwent VAD implant at age < 6 years with neurodevelopmental assessments available for 48/51 patients who survived to testing. Median age at implant was 0.63 years (IQR 0.20, 2.74), 37.5% were female and 39.6% had congenital heart disease. Optimal outcome occurred in 33% of patients. Optimal outcome was associated with female sex [OR 8.03 (95% CI 1.69–56.64) p = 0.007] and implant between 2015 and 2020 [OR 6.59 (95% CI 1.42–42.62) p = 0.016]. Neurological insult sustained pre‐post‐VAD [OR 0.10 (95% CI 0.01–0.63) p = 0.01] was associated with a non‐optimal outcome.
Conclusion
Optimal outcome was present in one‐third of patients. Protective factors were female sex and implant between 2015 and 2020. Neurological insult was associated with a non‐optimal outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
- Department of Cardiac Surgery, University of Alberta, Edmonton, Alberta, Canada.
- Department of Pediatrics, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada.
- School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Shannon Oliver, Ari R Joffe, Tara Pidborochynski, Charlene M T Robertson, Jennifer Conway
Zitieren
APA
Oliver, S., Buchholz, H., Freed, D. H., Jonker, V., Joffe, A. R., Saeidian, M., Dinu, I., Urschel, S., Pidborochynski, T., Atallah, J., Robertson, C. M. T., Zvonkovic, J., & Conway, J. (2026). Evaluating the Prevalence of Optimal Neurodevelopmental Outcome at 4.5‐Years in Children Previously on Ventricular Assist Device Support. Pediatric Transplantation. https://doi.org/10.1111/petr.70276
Vancouver
Oliver S, Buchholz H, Freed DH, Jonker V, Joffe AR, Saeidian M, et al. Evaluating the Prevalence of Optimal Neurodevelopmental Outcome at 4.5‐Years in Children Previously on Ventricular Assist Device Support. Pediatric Transplantation. 2026. doi:10.1111/petr.70276
BibTeX
@article{Oliver2026,
author = {Oliver, Shannon and Buchholz, Holger and Freed, Darren H and Jonker, De Villiers and Joffe, Ari R and Saeidian, Mahsa and Dinu, Irina and Urschel, Simon and Pidborochynski, Tara and Atallah, Joseph and Robertson, Charlene M T and Zvonkovic, Jessica and Conway, Jennifer},
title = {Evaluating the Prevalence of Optimal Neurodevelopmental Outcome at 4.5‐Years in Children Previously on Ventricular Assist Device Support},
journal = {Pediatric Transplantation},
year = {2026},
doi = {10.1111/petr.70276}
}
EUVIMED